Teriparatide, bisphosphonates and HRT to osteoporosis of woman

被引：0
|
作者：
Bazarra-Fernandez, A. [1 ]
Bazarra-Castro, M. A. [1 ]
机构：
[1] Med Santiago Univ, Santiago, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
    Li, Mingnian
    Ge, Zhuoqi
    Zhang, Benqi
    Sun, Li
    Wang, Zhongyuan
    Zou, Tao
    Chen, Qi
    ARCHIVES OF OSTEOPOROSIS, 2024, 19 (01)
  • [42] Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
    Chen, Liangshi
    Ji, Bomei
    Xia, Cong
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [43] Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates
    de Sousa, Isabel Oliveira
    Diniz, Erik Trovao
    Marques, Thyciara Fontenele
    Griz, Luiz
    Pereira Coutinho, Mario de Almeida
    Bandeira, Francisco
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 244 - 249
  • [44] Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients A meta-analysis
    Fan, Guiyong
    Zhao, Qun
    Lu, Pei
    Chen, Hao
    Tan, Wei
    Guo, Weixiao
    Liu, Chaoqun
    Liu, Jinlian
    MEDICINE, 2020, 99 (15) : E18964
  • [45] Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case-control study
    Yukishima, Toshitaka
    Ebina, Kosuke
    Etani, Yuki
    Noguchi, Takaaki
    Ohmura, Shin-ichiro
    Nakata, Ken
    Okada, Seiji
    Kobayakawa, Tomonori
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (03) : 531 - 538
  • [46] A Longitudinal Cohort Study of Weekly Teriparatide, Denosmab, and Bisphosphonates for Prevention of Vertebral Fractures in Glucocorticoid-Induced Osteoporosis
    Oshima, Hisaji
    Ushikubo, Mari
    Akiya, Kumiko
    Tanaka, Ikuko
    Tamaki, Shigenori
    Izumi, Keisuke
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
    Mingnian Li
    Zhuoqi Ge
    Benqi Zhang
    Li Sun
    Zhongyuan Wang
    Tao Zou
    Qi Chen
    Archives of Osteoporosis, 19 (1)
  • [48] BMD CHANGE AFTER ONE YEAR OF TREATMENT WITH DENOSUMAB OR BISPHOSPHONATES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS PRETREATED WITH TERIPARATIDE
    Kocjan, T.
    SabatiRajic, A.
    JensterleSever, M.
    Ostanek, B.
    Orehek, N.
    Marc, J.
    Pfeifer, M.
    Prezelj, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S341 - S342
  • [49] Teriparatide Therapy for Bisphosphonate-Associated Osteonecrosis of the Jaw in an Elderly Japanese Woman with Severe Osteoporosis
    Iwamoto, Jun
    Yago, Kaori
    Sato, Yoshihiro
    Matsumoto, Hideo
    CLINICAL DRUG INVESTIGATION, 2012, 32 (08) : 547 - 553
  • [50] TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
    ZIEGLER, R
    MEDIZINISCHE WELT, 1993, 44 (02): : 114 - 118
12345